Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective …

C Fabiani, A Vitale, D Rigante, G Emmi, A Bitossi… - Clinical …, 2019 - Springer
To compare the efficacy of adalimumab (ADA) and infliximab (IFX) in patients with non-
infectious intermediate uveitis, posterior uveitis, and panuveitis. Demographic, clinical …
被引用次数：66 相关文章

[引用][C] Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a …

C Fabiani, A Vitale, D Rigante, G Emmi, A Bitossi… - Clinical …, 2018 - cir.nii.ac.jp
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious
intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of …

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective …

C Fabiani, A Vitale, D Rigante, G Emmi… - Clinical …, 2019 - search.proquest.com
To compare the efficacy of adalimumab (ADA) and infliximab (IFX) in patients with non-
infectious intermediate uveitis, posterior uveitis, and panuveitis. Demographic, clinical …

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective …

C Fabiani, A Vitale, D Rigante, G Emmi… - CLINICAL …, 2019 - ricerca.uniba.it
To compare the efficacy of adalimumab (ADA) and infliximab (IFX) in patients with non-
infectious intermediate uveitis, posterior uveitis, and panuveitis. Demographic, clinical …

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective …

C Fabiani, A Vitale, D Rigante, G Emmi… - Clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
To compare the efficacy of adalimumab (ADA) and infliximab (IFX) in patients with non-
infectious intermediate uveitis, posterior uveitis, and panuveitis. Demographic, clinical …

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective …

C Fabiani, A Vitale, D Rigante, G Emmi… - CLINICAL …, 2019 - usiena-air.unisi.it
To compare the efficacy of adalimumab (ADA) and infliximab (IFX) in patients with non-
infectious intermediate uveitis, posterior uveitis, and panuveitis. Demographic, clinical …

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective …

C Fabiani, A Vitale, D Rigante, G Emmi… - CLINICAL …, 2019 - flore.unifi.it
To compare the efficacy of adalimumab (ADA) and infliximab (IFX) in patients with non-
infectious intermediate uveitis, posterior uveitis, and panuveitis. Demographic, clinical …

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective …

C Fabiani, A Vitale, D Rigante, G Emmi… - Clinical …, 2019 - search.ebscohost.com
To compare the efficacy of adalimumab (ADA) and infliximab (IFX) in patients with non-
infectious intermediate uveitis, posterior uveitis, and panuveitis. Demographic, clinical …

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis and panuveitis: a retrospective …

C Fabiani, A Vitale, D Rigante, G Emmi… - CLINICAL …, 2019 - publicatt.unicatt.it
To compare the efficacy of adalimumab (ADA) and infliximab (IFX) in patients with non-
infectious intermediate uveitis, posterior uveitis, and panuveitis. Demographic, clinical …

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective …

C Fabiani, A Vitale, D Rigante, G Emmi… - Clinical …, 2018 - europepmc.org
To compare the efficacy of adalimumab (ADA) and infliximab (IFX) in patients with non-
infectious intermediate uveitis, posterior uveitis, and panuveitis. Demographic, clinical …